Less than two weeks left to register for the 2012 NCRI Cancer Conference

Header for the 2012 NCRI Cancer Conference

NCRI Cancer Conference Newsletter

September 2012

Dear

The Conference is fast approaching - online registration closes on Sunday 30 September. Register now to guarantee your place.

Register online now

Registration closes at midnight (UK time) on Sunday 30 September 2012

Registration can be completed on the day. However, we highly recommend that you register in advance to avoid disappointment.

Already registered? Choose your sessions!

57 sessions to choose from

If you have already registered, please remember to choose your sessions, or amend your session choices, before registration closes on 30 September.

**Log in to make your selection**

Please note:

Some sessions may have changed since you registered and made your initial selection. For the most up to date list of sessions and speakers please view the Conference programme.

Whilst every effort is made to ensure that you can attend your chosen sessions, your selection does NOT guarantee you a place in the session of your choice. Places will be filled on a first come first served basis. You are therefore advised to get to sessions early to be sure of getting a place.

Interactive workshops on current issues in cancer research

The full Conference programme is available on the Conference website - please check this for further details about all confirmed speakers and session times.

As part of the programme, join us for

workshops providing opportunities for debate, interdisciplinary learning and interactive education.

After last year's popular commercial workshop covering the headlines of international conferences, Roche are hosting a similarly-themed workshop this year:

Roche logo

Roche:

Headlines of International Conferences in 2012 - a Roche-sponsored symposium

Tuesday 6 November, 13.00-14.00, Room 11

What have been the latest developments in cancer research and treatment? Taking the data from past congresses, the symposium will present an independent view of the headline data from this year's key congresses.

Roche Products Limited welcomes all NCRI delegates to attend this Roche-sponsored symposium and hear from a clinician's perspective how the highlights of congresses such as the American Society of Clinical Oncology Annual Meeting could impact on patient care in the UK.

As in previous Conferences, BACR will also be hosting two educational workshops:

1. Pre-clinical breast cancer models, hosted by Valerie Speirs (Leeds Institute of Molecular Medicine, UK)

2. Translation of radiation biology into meaningful clinical trials: All aboard!, hosted by Ricky Sharma (University of Oxford, UK)

Want a private meeting at the Conference?

Meeting booths - sponsored by Pfizer

Pfizer

A key component of the NCRI Cancer Conference is the opportunity to network with other delegates. We are therefore delighted to announce that there will be a number of meeting booths (with cabled internet connection) available again at this year's Conference to allow private meetings with other delegates, from 2-6 people.

You will be able to schedule meetings at the booking desk situated in Hall 2 during the Conference.

Hear the results of practice-changing trials at the Conference

The full Conference programme is available on the Conference website - please check this for further details about all confirmed speakers and session times.

A large number of very high-quality and practice-changing clinical trials were submitted to the Conference this year. You will be able to see these trials presented in the Clinical Trials Showcase on Tuesday 6 November:

Prostate cancer - androgen deprivation therapy (ADT) + radiation therapy (RT)

Malcolm Mason, Cardiff University, UK

NCRI ACT II: Squamous cancer of the anus - pattern and timing of disease recurrence

David Sebag-Montefiore, St James's Institute of Oncology, University of Leeds, UK

NET 01: Neuroendocrine tumours - capecitabine + streptozocin ± cisplatin

Graham Armstrong, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, UK

COG: Oesophageal cancer - gefitinib vs. placebo

David R Ferry, Russells Hall Hospital, Dudley, UK

You will also be able to choose from 6 proffered paper sessions covering a number of themes:

The cancer cell and model systems
Cancer awareness, early diagnosis and survivorship

Diagnosis and therapy

Radiotherapy and radiobiology

Full details will be available on the Conference website within the next week.

Search and cite abstracts

Speakers' abstracts, as well as all accepted abstracts (including late-breakers) will be available on the Conference website by mid-October for you to browse before attending the Conference. Please check the Conference website for further updates.

You will be able to search abstracts by type of presentation, theme, authors, keywords and other fields, or simply just browse the website for an overview of all the exciting new research that will be presented at the Conference.

Thank you for your interest in the NCRI Cancer Conference. Remember to register online before 30 September, and please help us by

We look forward to welcoming you to the Conference in November.

With best wishes,

NCRI Cancer Conference Secretariat

At Illumina, our vision is to be the leading provider of integrated solutions that advance the understanding of genetics and health. Our purpose is to improve human health by enabling our customers to accelerate the collection, analysis, and application of biological information.

Seek the Future: MiSeq® Grant Program

Research is your vehicle. Passion is your driver as you seek to make your mark on the future of genomic discovery.

The MiSeq Grant Program is an exciting opportunity to be 1 of 3 researchers to win a MiSeq system package, the industry's most accurate and easiest-to-use benchtop sequencer. From sample prep to automated analysis, MiSeq is the streamlined end-to-end sequencing solution that will help you shape the future in genomic science.

Visit www.illumina.com/miseqgrantprogram to access the official entry form and complete competition details.

The National Cancer Research Institute

The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry. It promotes co-operation in cancer research among the 22 member organisations for the benefit of patients, the public and the scientific community.